# Lamivudine

NDC: 33342-002
Generic name: Lamivudine
Labeler / Manufacturer: Macleods Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20190502

FDA application: ANDA090198

## Active ingredients

- LAMIVUDINE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"33342-002"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=33342-002
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1be30bcc-2d9f-4afc-8f09-adc840b3f2d9